Print PDF

Advertising & Promotion for Medical Products Conference

Promotional Challenges and Considerations for Rare Disease Treatments
11.03.2023 | 12:45-1:45 PM

According to FDA statistics, over 7,000 rare diseases affect more than 30 million people in the US. The collective number of diseases is large, but the number of patients affected by each disease is small, resulting in smaller clinical datasets. Panelists will explore the role of advertising and promotion in reaching and engaging with rare disease patient advocacy groups, including ultra-rare diseases, and implementing disease awareness campaigns without explicitly promoting specific drugs.


  • Dominick DiSabatino, Partner, Sheppard Mullin 

Click here to register. 

Practice Areas


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.